Selective Estrogen Receptor Degraders Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ZNTL | F | Zentalis Pharmaceuticals, Inc. | -2.52 | |
GTHX | F | G1 Therapeutics, Inc. | 4.90 | |
OLMA | D | Olema Pharmaceuticals, Inc. | 2.50 |
Related Industries: Biotechnology
Related Stock Lists:
Antiestrogens
Biopharmaceutical
Breast Cancer
Estrogen
Estrogen Receptor
Her2
Her2/Neu
Hormones
Treatment Of Breast Cancer
Cancer
Drugs
Epidermal Growth Factor Receptor
Fulvestrant
Receptor Positive
Clinical Medicine
Intracellular Receptors
Medicine
Metastatic Breast Cancer
Molecule Therapeutics
Protein Kinase Inhibitor
Related ETFs - A few ETFs which own one or more of the above listed Selective Estrogen Receptor Degraders stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.25 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 0.7 | |
CNCR | F | Loncar Cancer Immunotherapy ETF | 0.46 | |
LABD | F | Direxion Daily S&P Biotech Bear 3X Shares | 0.42 | |
XBI | C | SPDR S&P Biotech ETF | 0.26 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jul 1 | GTHX | G1 Therapeutics added to the Russell 2000® and 3000® Indexes |
Jul 1 | GTHX | G1 Therapeutics Added to the Russell 2000® and 3000® Indexes |
Related Industries:
Biotechnology
Related Stock Lists:
Antiestrogens
Biopharmaceutical
Breast Cancer
Estrogen
Estrogen Receptor
Her2
Her2/Neu
Hormones
Treatment Of Breast Cancer
Cancer
Drugs
Epidermal Growth Factor Receptor
Fulvestrant
Receptor Positive
Clinical Medicine
Intracellular Receptors
Medicine
Metastatic Breast Cancer
Molecule Therapeutics
Protein Kinase Inhibitor
- Selective Estrogen Receptor Degraders
Selective Estrogen Receptor Degraders (SERDs) are a class of drugs that target the estrogen receptor and reduce its activity. They are used to treat hormone-dependent breast cancer and other estrogen-related conditions. SERDs work by blocking the binding of estrogen to its receptor, thus reducing the amount of estrogen that can activate the receptor. This can help reduce the growth of cancer cells that rely on estrogen for growth and survival.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles